Organon & Co. — Director's Dealing 2022

Apr 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2022-03-31

Reporting Person: Milligan Sandra (Head of Research & Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-31	Restricted Stock Units	$	A	17892	Acquired	2025-03-31	Common Stock (17892)	Direct
2022-03-31	Stock Option (right to buy)	$34.93	A	55114	Acquired	2032-03-29	Common Stock (55114)	Direct

Footnotes

F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.

F2: These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025.

F3: The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025.